Trevi Therapeutics, Inc. (TRVI) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$56,273
Total Return
462.73%
CAGR
41.28%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +7.45% |
| Median | -0.45% |
| Best | +367.09% |
| Worst | -52.05% |
| % of Windows Positive | 48.5% |
1-Year (252 Trading Days)
| Average | +85.39% |
| Median | +68.50% |
| Best | +414.45% |
| Worst | -51.77% |
| % of Windows Positive | 79.8% |
3-Year (756 Trading Days)
| Average | +259.15% |
| Median | +172.73% |
| Best | +859.66% |
| Worst | +6.81% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -81.56% |
| Average Drawdown | -32.42% |
| Drawdown Duration | 249 Trading Days |
| Sortino Ratio | 1.41 |
| Calmar Ratio | 0.51 |
| CVaR (5%) | -10.12% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +12.14% (+49.54% ann.) | +$1214.06 | $0.00 | $0.00 | $0.00 |
| 2025 | +203.88% | +$20388.35 | $0.00 | $0.00 | $0.00 |
| 2024 | +207.46% | +$20746.31 | $0.00 | $0.00 | $0.00 |
| 2023 | -30.57% | $3056.99 | $0.00 | $0.00 | $0.00 |
| 2022 | +146.80% | +$14680.21 | $0.00 | $0.00 | $0.00 |
| 2021 | -67.69% | $6768.58 | $0.00 | $0.00 | $0.00 |
| 2020 | -35.47% | $3546.67 | $0.00 | $0.00 | $0.00 |
| 2019 partial | -52.47% (-68.07% ann.) | $5247.15 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 7, 2019 – February 19, 2020 | -29.49% | -35.80% | $2949.30 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -58.81% | -100.00% | $5881.33 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +25.10% | +43.37% | +$2509.63 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -70.83% | -68.93% | $7083.33 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +93.97% | +102.07% | +$9396.95 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +72.54% | +34.22% | +$7253.91 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +311.73% | +146.48% | +$31172.99 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.